Instrument Inactif

Communiqués Advanced Proteome Therapeutics Corp. Other OTC

Actions

Canadian Investment Regulatory Organization Trading Halt - APC.H	05/12	AQ
IIROC Trading Resumption - APC	17/01/23	AQ
IIROC Trading Halt - APC	17/01/23	AQ
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	04/08/22	AQ
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	13/04/22	NE
Advanced Proteome Therapeutics Provides Update on COVID Program	24/08/21	NE
Advanced Proteome Therapeutics Announces Appointment of Dr. Benjamin Krantz to CEO	21/07/21	NE
Advanced Proteome Therapeutics Announces Renowned Scientist to Join Scientific Advisory Board and New Chemistry Hire	09/06/21	NE
Advanced Proteome Therapeutics Announces Closing Final Tranche of Non-Brokered Private Placement	13/04/21	NE
Advanced Proteome Therapeutics Announces Increase of Non-Brokered Private Placement	11/03/21	NE
Advanced Proteome Therapeutics Announces a Non-Brokered Private Placement	01/03/21	NE
Advanced Proteome Therapeutics : IIROC Trading Resumption - APC	17/12/20	AQ
Advanced Proteome Therapeutics : IIROC Trading Halt - APC	17/12/20	AQ
Advanced Proteome Therapeutics Announces Dr. Benjamin Krantz to Join Company as CEO	17/12/20	NE
Advanced Proteome Therapeutics Provides Project Update	14/08/20	NE
Advanced Proteome Therapeutics : IIROC Trading Resumption - APC	09/07/20	AQ
Advanced Proteome Therapeutics Files Provisional IP for Compounds Targeting SARS-CoV-2	09/07/20	NE
Advanced Proteome Therapeutics : IIROC Trading Halt - APC	09/07/20	AQ
Advanced Proteome Therapeutics : Announces a Non-Brokered Private Placement	17/02/20	AQ

Aucun résultat pour cette recherche